KronoLife Awarded Proof of Concept Grant from TED Fund
KronoLife has received a Proof of Concept (POC) grant from the Technology and Innovation-Based Enterprise Development Fund (TED Fund) to support the research and development of a new longevity-focused dietary supplement formula.
The funded research centers on ZenoBlazt+ and ZenoGenez+, developed under the Evidence-First Longevity framework to evaluate their impact on healthy aging in middle-aged and elderly populations.
The key bioactive compounds in both formulations are designed to target senescent or Zombie cells, a critical biological mechanism associated with aging progression, accelerated physiological decline, and the development of non-communicable diseases. This grant marks another milestone in KronoLife’s commitment to advancing scientifically grounded longevity solutions from research validation to practical health applications.
